I. Exhibition Overview: WHX Dubai initiates a new era of Global medical cooperation
From February 9th to 12th, 2026, the original Arab Health medical Exhibition will be officially renamed WHX Dubai and grandly open at the Dubai Exhibition Centre. As the largest and most influential international medical equipment and technology expo in the Middle East and North Africa, WHX Dubai shoulders the mission of promoting the innovative development of the global medical and health industry. It is expected to attract over 4,000 exhibitors from more than 70 countries and over 100,000 professional visitors. This exhibition takes “Connecting Global Healthcare Innovations” as its theme, focusing on cutting-edge fields such as digital healthcare, intelligent diagnosis, and precise detection, and building a core platform for global healthcare enterprises to exchange technologies, expand markets, and achieve win-win cooperation.
Dubai, as the hub of the medical market in the Middle East, has an annual growth rate of 7.5% in its healthcare industry, and the market size is expected to exceed 30 billion US dollars by 2025. The renaming and upgrading of WHX Dubai not only marks the elevation of the exhibition’s strategic position in the global medical industry chain, but also highlights its precise response to the demands of emerging markets. The exhibition will feature three core sections: the diagnostic technology exhibition area, the smart healthcare exhibition area, and the medical equipment exhibition area. Through forms such as theme forums, product launches, and clinical case discussions, it will comprehensively showcase the latest achievements in global medical technology.
Ii. SEJOY Medical: Empowering Global Health with Innovative Diagnostic Technologies
As a leading enterprise in the global in vitro diagnostic (IVD) field, SEJOY Medical will showcase its full range of innovative testing products at WHX Dubai 2026, with booth number S13.E119. SEJOY Medical has been deeply engaged in the field of in vitro diagnostics for over 20 years. With the philosophy of “Precise detection, Safeguarding Life”, it has built a product matrix covering multiple scenarios such as chronic disease management, reproductive health, and infectious disease prevention and control. It has provided diagnostic support to over 100 million people in more than 120 countries and regions around the world.
At this exhibition, SEJOY Medical will focus on showcasing eight core product lines, covering technical platforms such as electrochemical detection, immunochromatography, and dry biochemistry, comprehensively meeting diverse needs including clinical diagnosis, home self-testing, and public health and epidemic prevention. Its products are characterized by “high precision, portability and intelligence”, and have passed international authoritative certifications such as ISO 13485, CE and FDA. They have been widely applied in hospital, physical examination center, community medical care and home health management scenarios.
Iii. Core Exhibit Analysis: Technological Innovation-driven Diagnostic Upgrade
(1) Chronic Disease Management Testing Series
Blood Glucose Monitor
The new generation of SEJOY no-code blood glucose meter adopts glucose dehydrogenase (FAD-GDH) technology, supports 0.5μL micro-blood collection, provides values within 5 seconds, and has strong anti-interference ability (not affected by substances such as maltose and galactose). The accompanying siphonic test strips are designed with a double-layer conductive coating to ensure the stability of the test, making them suitable for daily blood glucose monitoring of diabetic patients and rapid clinical screening.
Lipid Profile Analyzer
The portable five-in-one lipid detector can simultaneously test total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL-C), low-density lipoprotein (LDL-C), and the ratio of total cholesterol (TC) to total cholesterol (TC). It only requires 35μL of whole blood and can complete the test in 3 minutes. The device is equipped with a built-in USB module, which can achieve real-time data upload and trend analysis through data transmission, providing a convenient tool for cardiovascular disease risk assessment.
Hemoglobin Meter
In response to the demand for anemia screening, the SEJOY hemoglobin meter adopts the principle of colorimetry, with a detection range of 10-25g/dL and an accuracy error of ≤±0.5g/dL. The device weighs only 85g, is equipped with a high-definition LCD display, supports multi-language customization, and is suitable for primary medical care and large-scale population screening.
Multifunctional electrochemical instrument for blood glucose, uric acid, blood ketone and cholesterol
As the star product of this exhibition, this multi-functional detector integrates four detection functions: blood sugar, uric acid, blood ketone and total cholesterol. It uses multi-electrode disposable test strips to achieve “one needle, four measurements”. The device is equipped with intelligent algorithms to automatically correct hematocrit (hematocrit) interference, supporting dual sample types of venous blood and capillary blood, meeting the monitoring needs of comprehensive metabolic indicators for patients with chronic diseases.
(2) Reproductive Health Testing Series
Digital ovulation pregnancy test Ovarian Function multi-functional detection pen
This product integrates immunochromatography technology with intelligent electronic devices, capable of simultaneously detecting luteinizing hormone (LH), human chorionic gonadotropin (HCG), and anti-Mullerian hormone (AMH). Automatically interpret the test results and generate ovulation cycle predictions and ovarian reserve function, assisting women in scientific pregnancy preparation and reproductive health management.
Traditional Pregnancy Test Strip
The SEJOY early pregnancy test strip uses a colloidal gold double antibody sandwich method, with a sensitivity of 25mIU/mL, and can detect pregnancy within 7 days after conception. The test strips are packaged in anti-pollution aluminum foil, support direct addition of urine samples, and can be quickly interpreted within 3 minutes with an accuracy rate of over 99%. They are the mainstream products in the home self-testing market.
(3) Infectious Diseases and Public Health Testing Series
Infectious Disease Test Kit
It covers multiple pathogen detection kits such as COVID-19, influenza virus (A/B types), hepatitis A and B virus (HBV/HCV), syphilis (TP), etc. It adopts colloidal gold immunochromatography method, is easy to operate without instruments, and the results are available in 15 minutes. The product has been certified by multiple countries and has played a key role in epidemic prevention and control in many countries around the world.
Drug of Abuse Test Strip
The SEJOY drug testing series supports rapid screening for over 60 common drugs such as morphine, methamphetamine, marijuana, and cocaine, with detection thresholds that comply with international standards. Urine/saliva sample testing is adopted to quickly interpret the results, which is suitable for judicial authorities, drug rehabilitation institutions and workplace safety testing scenarios.
Iv. SEJOY’s Globalization Strategy and Market Layout
SEJOY Medical has always prioritized emerging markets as a strategic focus, with the Middle East being one of its core markets. Through the WHX Dubai exhibition, SEJOY will further deepen its cooperation with Middle Eastern countries, with a focus on expanding into high-end markets such as Saudi Arabia, the United Arab Emirates, and Qatar, and promoting the connection between chronic disease management products and local medical insurance systems.
V. Jointly Creating a New Future for Medical and Health Care
WHX Dubai 2026 is not only a grand feast of global medical technology, but also an important opportunity for SEJOY Medical to showcase its innovative strength and deepen international cooperation. Facing the rapid transformation of the global healthcare industry, SEJOY will continue to take technological innovation as its driving force, focus on unmet clinical needs, and provide global users with more accurate, convenient and intelligent diagnostic products.
We sincerely invite partners from the global medical industry to visit our booth (S13.E119) at SEJOY to discuss cooperation, join hands to promote the progress of in vitro diagnostic technology, and contribute to building a global health ecosystem where “everyone enjoys quality medical care”!
Exhibition Time: February 9th – 12th, 2026
Booth No. : S13.E119 (Dubai Exhibition Centre)
SEJOY Medical website: www.sejoy.com
Contact email: poct@sejoy.com
Post time: Dec-22-2025